Diabetes Research and Clinical Practice
Volume 86, Issue 1 , Pages 67-73 , October 2009

Association of glucose measures with total and coronary heart disease mortality: Does the effect change with time? The Rancho Bernardo Study

  • Beth E. Cohen

      Affiliations

    • General Internal Medicine Section, Department of Veterans Affairs Medical Center, San Francisco, United States
    • Department of Medicine, University of California, San Francisco, United States
    • Corresponding Author InformationCorresponding author at: VA Medical Center, General Internal Medicine Section (111A1), 4150 Clement Street; San Francisco, CA 94121-1598. Tel.: +1 415 221 4810x4851; fax: +1 415 379 5573.
    • ,
  • Elizabeth Barrett-Connor

      Affiliations

    • Department of Family and Preventive Medicine, Division of Epidemiology, University of California, San Diego, United States
    • ,
  • Christina L. Wassel

      Affiliations

    • Department of Family and Preventive Medicine, Division of Epidemiology, University of California, San Diego, United States
    • ,
  • Alka M. Kanaya

      Affiliations

    • Department of Medicine, University of California, San Francisco, United States
    • Division of General Internal Medicine, University of California, San Francisco, United States

Received 22 January 2009 ,Revised 25 June 2009 ,Accepted 14 July 2009.

References 

  1. Barrett-Connor E, Wingard DL. Normal blood glucose and coronary risk. BMJ. 2001;322:5–6
  2. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12. 4 years. Diabetes Care. 1999;22:233–240
  3. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann. Int. Med. 2004;141:413–420
  4. Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch. Int. Med. 2004;164:2147–2155
  5. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch. Int. Med. 2005;165:1910–1916
  6. DECODE. Study Group. The European Diabetes Epidemiology Group, Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch. Int. Med. 2001;161:397–405
  7. Meigs JB, Nathan DM, D’Agostino RB, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002;25:1845–1850
  8. Park S, Barrett-Connor E, Wingard DL, Shan J, Edelstein S. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care. 1996;19:450–456
  9. Port SC, Boyle NG, Hsueh WA, Quinones MJ, Jennrich RI, Goodarzi MO. The predictive role of blood glucose for mortality in subjects with cardiovascular disease. Am. J. Epidemiol. 2006;163:342–351
  10. Qiao Q, Pyorala K, Pyorala M, Nissinen A, Lindstrom J, Tilvis R, et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur. Heart J. 2002;23:1267–1275
  11. Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH, et al. Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch. Int. Med. 2002;162:209–216
  12. Sorkin JD, Muller DC, Fleg JL, Andres R. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care. 2005;28:2626–2632
  13. Qiao Q, Dekker JM, de Vegt F, Nijpels G, Nissinen A, Stehouwer CD, et al. Two prospective studies found that elevated 2-hr glucose predicted male mortality independent of fasting glucose and HbA1c. J. Clin. Epidemiol. 2004;57:590–596
  14. Menotti A, Lanti M, Kafatos A, Nissinen A, Dontas A, Nedeljkovic S, et al. The role of a baseline casual blood pressure measurement and of blood pressure changes in middle age in prediction of cardiovascular and all-cause mortality occurring late in life: a cross-cultural comparison among the European cohorts of the Seven Countries Study. J. Hypertension. 2004;22:1683–1690
  15. von Muhlen D, Langer RD, Barrett-Connor E. Sex and time differences in the associations of non-high-density lipoprotein cholesterol versus other lipid and lipoprotein factors in the prediction of cardiovascular death (The Rancho Bernardo Study). Am. J. Cardiol. 2003;91:1311–1315
  16. Schneider DL, Barrett-Connor EL, Morton DJ. Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study. JAMA. 1997;277:543–547
  17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972;18:499–502
  18. The Diabetes Control Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993;329:977–986
  19. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, et al. Tests of glycemia in diabetes. Diabetes Care. 2004;27:1761–1773
  20. Eilers PHC, Marx BD. Flexible smoothing with B-splines and penalties. Stat. Sci. 1996;11:89–102
  21. Sievenpiper JL, Leiter LA, Vuksan V. Intrasubject coefficient-of-variation corresponds to diagnostic reproducibility in diabetes screening. Can. J. Diabetes. 2002;62:623–630
  22. Centers for Disease Control Prevention (CDC) . Trends in intake of energy and macronutrients—United States 1971–2000. MMWR Morb Mortal Wkly Rep 53. 2004;80–82
  23. Lantz PM, House JS, Lepkowski JM, Williams DR, Mero RP, Chen J. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective Study of US adults. JAMA. 1998;279:1703–1708
  24. Sasso FC, Carbonara O, Nasti R, Campana B, Marfella R, Torella M, et al. Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. JAMA. 2004;291:1857–1863
  25. Kume S, Takeya M, Mori T, Araki N, Suzuki H, Horiuchi S, et al. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am. J. Pathol. 1995;147:654–667
  26. Ahmed N. Advanced glycation endproducts--role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 2005;67:3–21

PII: S0168-8227(09)00308-8

doi: 10.1016/j.diabres.2009.07.006

Diabetes Research and Clinical Practice
Volume 86, Issue 1 , Pages 67-73 , October 2009

Article Tools

* Image Usage & Resolution